Approval · Notice of Compliance 7083 · 2005
AGGRASTAT: Notice of Compliance 7083
Issued June 8, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7083
- Date
- June 8, 2005
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
Medicinal ingredients
- TIROFIBAN HCL 0.25 MG per ML
- TIROFIBAN HCL 5 MG per 100ML